1. Home
  2. SBCF vs WVE Comparison

SBCF vs WVE Comparison

Compare SBCF & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SBCF

Seacoast Banking Corporation of Florida

HOLD

Current Price

$32.75

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$7.58

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBCF
WVE
Founded
1926
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.4B
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
SBCF
WVE
Price
$32.75
$7.58
Analyst Decision
Buy
Strong Buy
Analyst Count
2
16
Target Price
$32.00
$29.50
AVG Volume (30 Days)
551.4K
6.5M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.32%
N/A
EPS Growth
10.56
N/A
EPS
1.57
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
$45.04
N/A
Revenue Next Year
$6.30
$85.67
P/E Ratio
$20.85
N/A
Revenue Growth
N/A
149.43
52 Week Low
$22.22
$5.02
52 Week High
$35.55
$21.73

Technical Indicators

Market Signals
Indicator
SBCF
WVE
Relative Strength Index (RSI) 63.23 36.43
Support Level $29.91 $6.79
Resistance Level $33.04 $7.63
Average True Range (ATR) 0.62 0.44
MACD 0.24 0.22
Stochastic Oscillator 77.26 79.41

Price Performance

Historical Comparison
SBCF
WVE

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company. The company provides integrated financial services, including commercial and consumer banking, wealth management, and mortgage and insurance services, to customers across Florida through branch, mobile, and online banking solutions. It maintains day-to-day operations, particularly in the areas of operations, treasury management systems, information technology, and security. The company has one reportable segment that provides these integrated financial services, with segment revenues driven mainly by interest and fees on loans, interest on cash and cash equivalents, and investment securities, and fees on depository products and services.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: